| 51 |
16407140 | Activation of the Keap1/Nrf2 pathway for neuroprotection by electrophilic [correction of electrophillic] phase II inducers. | 2006 Jan 17 |
1 |
| 52 |
16537594 | Astrocytes survive chronic infection and cytopathic effects of the ts1 mutant of the retrovirus Moloney murine leukemia virus by upregulation of antioxidant defenses. | 2006 Apr |
1 |
| 53 |
16860917 | Toxicophores: investigations in drug safety. | 2006 Sep 1 |
1 |
| 54 |
15985429 | Specific patterns of electrophile adduction trigger Keap1 ubiquitination and Nrf2 activation. | 2005 Sep 9 |
2 |
| 55 |
16359182 | Identification of sensor cysteines in human Keap1 modified by the cancer chemopreventive agent sulforaphane. | 2005 Dec |
2 |
| 56 |
14616092 | Cellular mechanisms of redox cell signalling: role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products. | 2004 Mar 1 |
1 |
| 57 |
14871400 | Stress protein activation by the cyclopentenone prostaglandin 15-deoxy-delta12,14-prostaglandin J2 in human mesangial cells. | 2004 Mar |
1 |
| 58 |
15477009 | Induction of detoxifying enzymes by garlic organosulfur compounds through transcription factor Nrf2: effect of chemical structure and stress signals. | 2004 Nov 15 |
1 |
| 59 |
15479833 | Activation of transcription factor Nrf-2 and its downstream targets in response to moloney murine leukemia virus ts1-induced thiol depletion and oxidative stress in astrocytes. | 2004 Nov |
5 |
| 60 |
14500406 | NADPH oxidase activity is essential for Keap1/Nrf2-mediated induction of GCLC in response to 2-indol-3-yl-methylenequinuclidin-3-ols. | 2003 Sep 1 |
1 |